Search for: "Robert Andrews" Results 301 - 320 of 4,317
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 May 2023, 1:52 pm by Kluwer Patent blogger
    More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade:… [read post]
17 May 2023, 9:45 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
16 May 2023, 2:51 am by Seán Binder
Andrew McDonald reports for POLITICO. [read post]
16 May 2023, 12:55 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
15 May 2023, 7:00 pm by Sabrina I. Pacifici
In Custodia Legis, Andrew Weber: “In April, Robert shared the news about how we enhanced the display of historical bill text on Congress.gov. [read post]
15 May 2023, 4:00 am by Jim Sedor
Supreme Court Tosses Convictions of Percoco, Kaloyeros, Developers” by Robert Gavin for Albany Times Union Oregon: “Oregon Lawmakers May Consider Boosting Elected Officials’ Pay, Passing Ethics Reforms in Wake of Shemia Fagan’s Resignation” by Grant Stringer (Portland Oregonian) for MSN Lobbying California: “Should Nonprofits Have to Register as Lobbyists in Long Beach? [read post]
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
12 May 2023, 4:31 am by Kluwer Patent blogger
  More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade:… [read post]
12 May 2023, 2:46 am by Seán Binder
Andrew Gray reports for Reuters. [read post]
11 May 2023, 2:21 am by Aida Tohala (Bristows)
On 4 May 2023, a mere two weeks after the conclusion of the hearing, the Court of Appeal handed down its decision in Sandoz and Teva v BMS. [read post]
10 May 2023, 1:20 pm by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
8 May 2023, 7:33 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
6 May 2023, 6:30 am by Guest Blogger
In my view, however, Suk’s broader account better supports Andrew Koppelman’s Thirteenth Amendment theory, which she also references. [read post]
5 May 2023, 5:38 am by Bart van Wezenbeek (Hoffmann Eitle)
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]
4 May 2023, 9:05 pm by renholding
It is a common refrain, mostly on the political right, that considering environmental, social, and governance (“ESG”) factors when investing is probably illegal.[1] The basis for this argument derives from the fiduciary duty of loyalty and its corollary, the “sole interest” or “exclusive benefit” rule, enshrined in both federal and state law, which prohibits fiduciaries from investing for any purpose other than the financial well-being of the beneficiary. [read post]
4 May 2023, 9:01 pm by renholding
Insider Giving, 71 Duke L.J. 619-700 (2021), Avci, S Burcu; Schipani, Cindy A; Seyhun, H Nejat; Verstein, Andrew. [read post]
In an earlier post I explained the issues that the proposed EU Regulation on SEPs intends to address, and why neither the market nor the courts solve them. [read post]
3 May 2023, 9:58 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational… [read post]